Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
11.74
+0.04 (0.34%)
Nov 6, 2026, 11:28 AM CST

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
772.68935.65933.041,027974.141,083
Other Revenue
14.0914.098.8837.1427.1219.86
786.77949.74941.921,0641,0011,103
Revenue Growth
-22.43%0.83%-11.48%6.27%-9.22%30.81%
Cost of Revenue
327.13330.72360.45321.43279.05230.42
Gross Profit
459.64619.03581.48742.65722.22872.6
Selling, General & Admin
144.63160.28169.4213.2219.26201.91
Research & Development
113.8396.4186.1288.51102.7580
Other Operating Expenses
5.961.28-0.93-0.826.295.92
Operating Expenses
282.81247.8266.47385.36339.01296.9
Operating Income
176.83371.23315.01357.29383.21575.71
Interest Expense
---4.77-8.16-5.45-1.81
Interest & Investment Income
25.6463.8373.1794.1275.6971.86
Currency Exchange Gain (Loss)
-0.89-0.8900.05--
Other Non Operating Income (Expenses)
19.261.15-0.72-0.21-0.2-0.27
EBT Excluding Unusual Items
220.85435.31382.69443.1453.25645.48
Impairment of Goodwill
---3.31---
Gain (Loss) on Sale of Investments
22.8533.2730.99-10.191.44-
Gain (Loss) on Sale of Assets
0.75-0.93---
Asset Writedown
-8.82-1.28-0.86-1.72-0.14-1.57
Legal Settlements
-----0.82
Other Unusual Items
18.0614.2427.726.3912.0615.32
Pretax Income
253.69481.54438.13457.58466.61660.05
Income Tax Expense
28.8864.656.646257.4689.41
Earnings From Continuing Operations
224.81416.94381.49395.58409.15570.64
Minority Interest in Earnings
2.181.780.860.350.370.11
Net Income
226.99418.72382.35395.93409.52570.74
Net Income to Common
226.99418.72382.35395.93409.52570.74
Net Income Growth
-50.60%9.51%-3.43%-3.32%-28.25%27.45%
Shares Outstanding (Basic)
467465466466465464
Shares Outstanding (Diluted)
467465466466465464
Shares Change
-0.51%-0.22%0.10%0.10%0.29%20.20%
EPS (Basic)
0.490.900.820.850.881.23
EPS (Diluted)
0.490.900.820.850.881.23
EPS Growth
-50.35%9.76%-3.53%-3.41%-28.46%6.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
251.73344.66285.74433.53320.86156.82
Free Cash Flow Per Share
0.540.740.610.930.690.34
Dividend Per Share
0.6400.6400.4300.4300.1900.190
Dividend Growth
48.84%48.84%0%126.32%0%-34.48%
Gross Margin
58.42%65.18%61.73%69.79%72.13%79.11%
Operating Margin
22.48%39.09%33.44%33.58%38.27%52.19%
Profit Margin
28.85%44.09%40.59%37.21%40.90%51.74%
Free Cash Flow Margin
32.00%36.29%30.34%40.74%32.05%14.22%
EBITDA
291.25482.99423.23470.54480.16638.35
EBITDA Margin
37.02%50.85%44.93%44.22%47.95%57.87%
D&A For EBITDA
114.42111.76108.22113.2496.9562.64
EBIT
176.83371.23315.01357.29383.21575.71
EBIT Margin
22.48%39.09%33.44%33.58%38.27%52.19%
Effective Tax Rate
11.38%13.41%12.93%13.55%12.31%13.55%
Revenue as Reported
211.88949.74941.921,0641,0011,103
Advertising Expenses
-25.4625.734.12.872.96